Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02306265 · ClinicalTrials.gov registry record · NA
Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT02306265 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 250 participants.
The verdict
NCT02306265, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
The aim of this recruitment plan (ADAPT-SCR) is to collect image and other data on both digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM) from asymptomatic women undergoing screening mammography.
Interventions
- DEVICE FFDM
- DEVICE DBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-07-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02306265
The ClinicalTrials.gov registry entry for NCT02306265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FFDM is the first listed.
NCT02306265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02306265 about?
NCT02306265 is a clinical study titled "Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography". The aim of this recruitment plan (ADAPT-SCR) is to collect image and other data on both digital breast tomosynthesis (DBT) and full-field digital mammography (FFDM) from asymptomatic women undergoing screening mammography.
What is the current status of trial NCT02306265?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2015-05. Estimated completion is 2017-07-07.
What interventions are being tested in trial NCT02306265?
The interventions under investigation include: FFDM (DEVICE), DBT (DEVICE).
Who is sponsoring clinical trial NCT02306265?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.